ROBERT L. ZERBE

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Vericel Corp

Filing Date Source Excerpt
2011-02-15 Robert L. Zerbe is listed as a director with no mention of software or technical background.
2011-04-14 Dr. Zerbe received his M.D. from the Indiana University School of Medicine, and has completed post-doctoral work in internal medicine, endocrinology and neuroendocrinology at Indiana University and the National Institutes of Health.
2012-04-16 Dr. Zerbe received his M.D. from the Indiana University School of Medicine, and has completed post-doctoral work in internal medicine, endocrinology and neuroendocrinology at Indiana University and the National Institutes of Health.
2013-03-22 Dr. Zerbe received his M.D. from the Indiana University School of Medicine, and has completed post-doctoral work in internal medicine, endocrinology and neuroendocrinology at Indiana University and the National Institutes of Health.
2013-09-05 Robert L. Zerbe(4) - Includes 252,966 shares issuable upon exercise of options held by Dr. Zerbe that are exercisable within the 60-day period following August 31, 2013.
2014-03-31 Dr. Zerbe received his M.D. from the Indiana University School of Medicine, and has completed post-doctoral work in internal medicine, endocrinology and neuroendocrinology at Indiana University and the National Institutes of Health.
2014-10-21 Director Compensation table and related descriptions do not mention any software-related technical skills for Robert L. Zerbe.
2015-03-25 Dr. Zerbe received his M.D. from the Indiana University School of Medicine, and has completed post-doctoral work in internal medicine, endocrinology and neuroendocrinology.

Data sourced from SEC filings. Last updated: 2025-10-11